Gerald L. Ray & Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$401K Sell
7,930
-420
-5% -$19.8K 0.05% 247
2017
Q2
$317K Sell
8,350
-1,025
-11% -$40.4K 0.04% 262
2017
Q1
$361K Sell
9,375
-20
-0.2% -$602 0.05% 246
2016
Q4
$208K Sell
9,395
-2,941
-24% -$60.4K 0.03% 298
2016
Q3
$197K Sell
12,336
-4,265
-26% -$48.7K 0.03% 309
2016
Q2
$137K Sell
16,601
-45
-0.3% -$401 0.02% 297
2016
Q1
$117K Buy
16,646
+3,000
+22% +$15.1K 0.02% 291
2015
Q4
$73K Sell
13,646
-6,636
-33% -$42.4K 0.01% 299
2015
Q3
$131K Buy
+20,282
New +$212K 0.02% 291

Other funds holding CC

Gerald L. Ray & Associates's CC Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Chemours (CC) stake by 5% in Q3 2017, selling an estimated $19.8K and leaving 7,930 shares worth $401K. The position accounts for 0.05% of the portfolio, ranked #247.

Gerald L. Ray & Associates first reported a position in CC in Q3 2015 and has held it in 9 quarters since. 500 funds tracked by Wall St. Rank hold CC as of Q3 2017.

  • Gerald L. Ray & Associates held 7,930 shares of Chemours worth $401K as of Q3 2017.
  • Gerald L. Ray & Associates sold 420 Chemours shares in Q3 2017, an estimated $19.8K.
  • Chemours made up 0.05% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #247 holding.
  • Gerald L. Ray & Associates first reported a position in Chemours in Q3 2015 and has held it in 9 quarters since.
  • 500 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.